Rockwell Medical, Inc. (NASDAQ:RMTI), SuperMedia Inc. (NASDAQ:SPMD), and Cardiome Pharma Corp. (NASDAQ:CRME) Added to Growing Stock Report's NASDAQ Decliners Watch List.

New York, NY -- (SBWIRE) -- 03/21/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Rockwell Medical, Inc. (NASDAQ:RMTI), SuperMedia Inc. (NASDAQ:SPMD), and Cardiome Pharma Corp. (NASDAQ:CRME).

Rockwell Medical, Inc. (NASDAQ:RMTI) an integrated biopharmaceutical company that engages in the manufacture, sale, and distribution of hemodialysis concentrates/dialysates targeting the end-stage renal disease, chronic kidney disease, and iron deficiency anemia in the United States and internationally closed down in its previous session (-6.86%) on 2,833,321 shares traded after Rockwell Medical announced that it has entered into definitive agreements to sell 4.3M common shares at $3.00 per share in a registered direct offering for an aggregate offering amount of approximately $12.9M. Rockwell Medical, Inc. (NASDAQ:RMTI) is currently down (-70.47%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Rockwell Medical, Inc. (NASDAQ:RMTI)

SuperMedia Inc. (NASDAQ:SPMD) a company that operates as a yellow pages directory publisher in the United States closed down in its previous session (-13.60%) on 287,462 shares traded after Dex One Corp and SuperMedia Inc have both filed for bankruptcy protection after the directories publishers failed to win the full support of senior secured lenders for a change to a credit agreement needed to complete their planned merger. SuperMedia Inc. (NASDAQ:SPMD) is currently down (-23.27%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about SuperMedia Inc. (NASDAQ:SPMD)

Cardiome Pharma Corp. (NASDAQ:CRME) a research-based biopharmaceutical company that focuses on the discovery, development, and commercialization of drugs to treat or prevent cardiovascular and other diseases closed down in its previous session (-8.24%) on 1,154,367 shares traded after Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Cardiome Shareholders Vote in Favor of Share Consolidation. Cardiome Pharma Corp. (NASDAQ:CRME) is currently down (-62.35%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Cardiome Pharma Corp. (NASDAQ:CRME)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com